| Authors: |
Akbarialiabad H; Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia.; Australasian Blistering Diseases Foundation (ABDF), Sydney, New South Wales, Australia., Schmidt E; Department of Dermatology and Lübeck Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany., Patsatsi A; Center of Expertise on AIBD, 2nd Dermatology Department, Aristotle University School of Medicine, Papageorgiou General Hospital, Thessaloniki, Greece., Lim YL; National Skin Centre, Singapore, Singapore.; Yong Loo Lin School of Medicine, Singapore, Singapore.; Lee Kong Chian School of Medicine, Singapore, Singapore., Mosam A; Department of Dermatology, Inkosi Albert Luthuli Central Hospital and Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa., Tasanen K; Department of Dermatology and Medical Research Center Oulu, Oulu University Hospital, Oulu, Finland.; Research Unit of Clinical Medicine, Faculty of Medicine, University of Oulu, Oulu, Finland., Yamagami J; Department of Dermatology, Tokyo Women's Medical University, Tokyo, Japan., Daneshpazhooh M; Autoimmune Bullous Diseases Research Center, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran., De D; Department of Dermatology, Postgraduate Institute of Medical Education and Research, Chandigarh, India., Cardones ARG; Division of Dermatology, Department of Internal Medicine, University of Kansas Medical Center, Lawrence, KS, USA., Joly P; Dermatology Department, Rouen University Hospital, INSERM U1234, Normandie University, Rouen, France. pascal.joly@chu-rouen.fr., Murrell DF; Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia. d.murrell@unsw.edu.au.; Australasian Blistering Diseases Foundation (ABDF), Sydney, New South Wales, Australia. d.murrell@unsw.edu.au.; Department of Dermatology, St George Hospital, Sydney, New South Wales, Australia. d.murrell@unsw.edu.au. |
